Catalent Inc
NYSE:CTLT

Watchlist Manager
Catalent Inc Logo
Catalent Inc
NYSE:CTLT
Watchlist
Price: 63.5 USD 0.03%
Market Cap: 11.5B USD
Have any thoughts about
Catalent Inc?
Write Note

P/E
Price to Earnings

-27.8
Current
20.8
Median
21.8
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-27.8
=
Market Cap
11.5B USD
/
Net Income
-413m USD
All Countries
Close
Market Cap P/E
US
Catalent Inc
NYSE:CTLT
11.5B USD -27.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY -5 347 888.9
US
Eli Lilly and Co
NYSE:LLY
756.2B USD 90.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP -15 783.5
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 29
US
Johnson & Johnson
NYSE:JNJ
350.6B USD 23.9
US
Merck & Co Inc
NYSE:MRK
252B USD 20.7
CH
Roche Holding AG
SIX:ROG
200.1B CHF 17.4
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 31.5
CH
Novartis AG
SIX:NOVN
171.5B CHF 10.8
US
Pfizer Inc
NYSE:PFE
151.5B USD 35.6
Earnings Growth P/E to Growth
US
Catalent Inc
NYSE:CTLT
Average P/E: 32.4
Negative Multiple: -27.8
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
90.3
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.9
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.6
719%
0

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
56.2
2-Years Forward
P/E
41.1
3-Years Forward
P/E
26

See Also

Discover More